Significant variation in P2Y12 inhibitor use after peripheral vascular intervention in Medicare beneficiaries.

Abstract

UNLABELLED There is no consensus regarding whether to use antithrombotic medications in patients with peripheral artery disease after lower-extremity peripheral vascular intervention. OBJECTIVES The main hypothesis is that significant variation exists regarding use of antithrombotic medications after lower-extremity peripheral vascular intervention. We… (More)
DOI: 10.1016/j.ahj.2016.06.002

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics